Related by context. All words. (Click for frequent words.) 65 Phase Ib II 65 OvaRex R 64 RhuDex ® 64 Cloretazine ® 64 BLP# Liposome Vaccine 64 Phase III TRIST 63 YONDELIS 63 WILEX 63 Phase Ib study 63 CRMD# 63 M Vax 63 oral ridaforolimus 63 Somatuline R Autogel R 63 OvaRex ® MAb 63 trastuzumab DM1 T DM1 63 PDE4 inhibitor 63 Oasmia 63 ProLindac TM 63 Dalbavancin 63 PrevOnco 63 Phase IIb III 63 Phase IIb clinical trials 63 Uvidem 62 HuCAL antibodies 62 Immunotherapeutic 62 SinuNase ™ 62 UPLYSO 62 Stimuvax R 62 GTC recombinant form 62 HDAC Inhibitor 62 Arno Therapeutics 62 TRO# 62 Personalized Immunotherapy 62 lexidronam injection 62 OPAXIO TM 62 Nitec 62 PRECISE trial 62 forodesine 62 Luveniq 62 novel therapeutic antibodies 62 mifamurtide 62 BLA filing 62 KYTHERA 62 LEVADEX ™ 62 Dr. Cauwenbergh 61 Ceflatonin 61 Zenvia ™ 61 DRAXIMAGE 61 immatics 61 IMA# 61 Loramyc R 61 Proxinium TM 61 Alvesco R 61 oral prodrug 61 TOCOSOL Paclitaxel 61 immunotherapeutic vaccine 61 Silodosin 61 Phase #b/#a clinical 61 EnzymeRx 61 tramiprosate Alzhemed TM 61 Clavis Pharma 61 ARRY # 61 TRISENOX 61 Estybon ™ 61 Civacir 61 MAA submission 61 Hedgehog antagonist 61 Glufosfamide 61 Junovan TM 61 Marketing Authorisation Application 61 HDL Mimetic Peptide 61 NPC 1C 61 Aegera 61 Kamada AAT 61 Icatibant 61 PNP inhibitor 61 Sopherion 61 Stragen 61 TBC# 61 DermTech International 61 UVIDEM 61 Manja Bouman CEO 61 INCB# [001] 61 Alseres 61 Ulrich Dauer CEO 61 Proteo 61 rALLy clinical trial 60 Romidepsin 60 depsipeptide 60 Tovaxin TM 60 Metaphore 60 investigational humanized monoclonal antibody 60 subsidiaries visit http:/www.apricusbio.com 60 BRIM2 60 Oceana Therapeutics 60 mertansine 60 BioAlliance 60 Dacogen injection 60 Fovea Pharmaceuticals 60 MOZOBIL 60 ANTEGREN 60 FluoroPharma 60 G#DT 60 Bicifadine 60 Kiadis Pharma 60 investigational immunotherapy 60 RIGScan CR 60 DPX Survivac 60 Tezampanel 60 ruxolitinib 60 obatoclax 60 Somatuline R Depot 60 Helsinn 60 Surfaxin LS 60 MAGE A3 ASCI 60 Myocet 60 mitogen activated ERK kinase 60 telomerase therapeutic 60 GATTEX TM 60 JAK1 60 Combination REOLYSIN R 60 ELACYT 60 Proellex TM 60 Panzem R NCD 60 Cavit Sciences Inc. 60 Dacogen TM 60 Virulizin R 60 ZEVALIN ® 60 Ceflatonin R 60 Saforis 60 Gastrotech 60 Qutenza TM 60 Medidur ™ FA 60 Telatinib 60 PNT# 60 PANVAC VF 60 LibiGel ® 60 Creabilis Therapeutics 60 ERYtech Pharma 60 molecular imaging radiopharmaceutical 60 ganetespib 60 deforolimus 60 ASCO GI 60 L BLP# 60 GRNVAC1 60 Cerimon 60 Preclinical Development 60 LHRH antagonist 60 Harry Palmin President 60 acyclovir Lauriad R 60 Clolar ® 60 Initiates Clinical 59 Allovectin 7 59 phase IIa clinical 59 Scancell 59 MEPACT 59 successfully commercialize Iluvien 59 SUCCEED trial 59 Cloretazine R VNP#M 59 antibody MAb 59 candidate deforolimus 59 Affimed Therapeutics AG 59 Anthony Giovinazzo 59 Initiates Phase III 59 Neogenix Oncology 59 PI3K/Akt pathway inhibitor 59 Yondelis ® 59 alvespimycin 59 budesonide MMX Phase III 59 leading oral taxane 59 GMX# 59 Phase Ib clinical 59 EndoTAG TM -1 59 radiation sensitizer 59 Affimed 59 Ercole Biotech 59 CR# vcMMAE 59 ThermoDox ® clinical 59 Tesetaxel 59 Æterna Zentaris 59 Preotact 59 KRYSTEXXA TM pegloticase 59 atacicept 59 Bafetinib 59 Targretin capsules 59 ThromboGenics commented 59 PDX pralatrexate 59 ViroStatics 59 Gentamicin Surgical Implant 59 Protalex Inc. 59 tezampanel NGX# 59 Initiates Enrollment 59 romidepsin 59 HuMax TAC 59 Altastaph 59 Biopartners 59 Talabostat 59 Xyrem ® 59 Angiox ® 59 Pertuzumab 59 Adenuric R 59 vidofludimus 59 Somanta 59 Metastatic Melanoma 59 ENZON 59 Multiferon R 59 Sigma Tau SpA 59 tiapamil 59 Immune Response Corporation 59 TASKi2 59 Rhein Biotech GmbH 59 ISTODAX 59 RhuDex TM 59 IL# PE#QQR 59 PregLem 59 Panzem R 59 octreotide implant 59 HDL Selective Delipidation 59 Ocrelizumab 59 Temsirolimus 59 Phase IIIb clinical 59 Loramyc 59 Evoltra ® 59 Onco TCS 59 Phase 2b Clinical Trial 59 Meritage Pharma 59 glucokinase activator 59 XTLbio 59 targeted radiotherapeutic 59 SYGNIS 59 VaxImmune 59 Veregen TM 59 registrational 59 ATL/TV# 59 Pazopanib 59 seliciclib CYC# 59 MOVIPREP R 59 StaphVAX R 59 Endovasc 59 PROSTVAC ® 59 targeted antifolate 59 ONCONASE R 59 OncoVEX GM CSF 59 Davanat 59 fosbretabulin 59 XYOTAX TM 59 Hsp# Inhibitor 59 Delenex 59 IIa trial 59 BAY #-# 59 Cloretazine R 59 markets HP Acthar 59 Genasense ® 59 NeuVax 59 ProFibrix 59 ACOMPLIA R 59 Alligator Bioscience AB 59 Polyphenon ® E 59 Hedgehog Pathway Inhibitor 59 zanolimumab 59 Hematide ™ 59 PROSTVAC TM 59 Archexin 59 intranasal formulation 59 CVac 59 KNS # 59 MAXY alpha 59 Evoltra 59 Orapred ODT 59 zileuton IV 59 oral taxane 59 Phase IIb trials 59 registrational trial 59 Opexa 59 liver resection surgeries 59 oncolytic virus therapies 58 DYNEPO 58 Revotar 58 Alferon N 58 Tibotec Pharmaceuticals Ltd. 58 Guanilib 58 cathepsin K inhibitor 58 Factor VIIa 58 Corautus 58 Receives Orphan Drug Designation 58 PF # [002] 58 URG# 58 initiated Phase Ib 58 ProEthic Pharmaceuticals 58 Safi Bahcall Ph.D. 58 Enobia 58 Kuvan R 58 BrachySil TM 58 Phase #b/#a 58 Cloretazine 58 vosaroxin 58 Circ Pharma 58 BRIM3 58 GW# [003] 58 SYCREST 58 MEK inhibitor 58 Initiates Phase II 58 Anticalin ® 58 please visit www.advaxis.com 58 ENMD # 58 herpetic keratitis 58 CCR9 antagonist 58 SUTENT ® 58 AFRS TM 58 IoGen 58 HIV integrase inhibitor 58 GLASSIA 58 ATryn R 58 Phase 2a clinical trials 58 Cellegesic 58 Vaccinex 58 Pliaglis 58 Anturol TM 58 therapeutic monoclonal antibodies 58 Argatroban 58 Ergomed 58 epigenetic therapies 58 RHEI Pharmaceuticals 58 AAG geldanamycin analog 58 cMET 58 TRANSDUR Bupivacaine 58 YONDELIS R 58 BioNumerik 58 HQK 58 Oglemilast 58 ATL# [001] 58 including eniluracil ADH 58 Azedra 58 TapImmune 58 vinorelbine tartrate 58 PRTX 58 Retacrit 58 ProBioGen 58 Epiphany Biosciences 58 Velcade bortezomib 58 Alzhemed TM 58 ARISE Phase III 58 neratinib 58 AZILECT ® 58 RhuDex 58 Fx #A 58 VitiGam 58 Prima BioMed 58 human IgG1 monoclonal 58 HCV polymerase 58 Kahalalide F 58 phase IIb trial 58 Ascenta Therapeutics 58 ImmunoCellular Therapeutics 58 Hybridon 58 Ganite ® 58 Completes Patient Enrollment 58 enzastaurin 58 Urocidin TM 58 Oracea ® 58 histamine dihydrochloride 58 ELND-#/AZD-# 58 QuikByte 58 Blinatumomab 58 ThromboGenics 58 Plicera 58 LEUKINE 58 Aegerion 58 Phenomix Corporation 58 Octreolin 58 Neuradiab 58 Accentia Biopharmaceuticals 58 Intravenous CP 58 Afferent Pharmaceuticals 58 Lodotra 58 AP# [003] 58 MEND CABG II 58 PhaseBio 58 Trofex 58 Tibotec BVBA 58 Deforolimus 58 Bionutrics 58 Evoltra TM 58 StemEx R 58 Nanobody 58 Loïc Maurel MD 58 Ambrilia Biopharma 58 Fresenius Biotech 58 Teysuno 58 Nipent R 58 Virosome Biologicals 58 Novosom 58 Plenaxis R 58 UCB Pharma SA 58 Tanespimycin 58 NEBIDO 58 Chemophase 58 LibiGel ® testosterone gel 58 Dr. Damaj 58 inhaled AAT 58 Ruconest 58 Chimigen TM 58 apricitabine ATC 58 Guerbet 58 torezolid phosphate 58 ASONEP 58 Allovectin 7 ® 58 TEMODAL 58 oral picoplatin 58 HuMax EGFr 58 AspenBio 58 Romiplostim 58 ADVEXIN p# therapy 58 phase IIb clinical 58 SARcode 58 eniluracil 58 Curon Medical 58 BioGeneriX 58 tezampanel 58 Bellicum Pharmaceuticals Inc. 58 Bioral Amphotericin B 58 Chemokine Therapeutics 58 NP2 Enkephalin 58 pan HDAC inhibitor 58 Exherin TM 58 Oracea TM 58 SCOLR Pharma 58 tafamidis 58 IRX 2 58 Bezielle 58 Pronova BioPharma 58 AmpliMed 58 TLR9 agonist 58 Aflibercept 58 rxRNA 58 Cysview 58 HuMax CD4 58 Troxatyl 58 dextromethorphan quinidine 58 Bioheart Inc. 58 non nucleoside inhibitor 58 novel histone deacetylase 58 Ketotransdel 58 AB OMXS BINV 58 Zemplar Capsules 57 novel oral anticoagulant 57 CA9 SCAN 57 EOquin TM 57 Cardioxyl Pharmaceuticals 57 ADVANCE PD 57 Veregen R 57 Fibrillex TM 57 PRESEPT Study 57 casopitant 57 StemEx 57 pradefovir 57 Ceragenix 57 Varespladib 57 Onrigin 57 Elisabeth Lindner CEO 57 eprotirome 57 DeveloGen 57 OncoVEX 57 AEG# 57 www.accentia.net 57 Urocidin 57 EP #R 57 elbion 57 Virulizin ® 57 BXT # 57 lorvotuzumab mertansine 57 Indomethacin 57 Dr. Arndt Schottelius 57 investigational HCV polymerase 57 TransVax tm 57 PDE# inhibitors 57 Fabry Disease 57 CCR5 antagonist 57 JAK2 Inhibitor 57 therapeutic monoclonal antibody 57 Juvaris 57 NerPharMa 57 Simulect 57 Cetrorelix 57 APTIMA HPV assay 57 beta 1a 57 CAMPATH 57 SNS# T 57 Bendamustine 57 Nasdaq PGNX today 57 IAP inhibitor 57 Peptimmune 57 Paladin Labs 57 GVAX ® 57 MoxDuo ® 57 initiate Phase 1b 57 faropenem 57 Successfully Completes Phase 57 Mr. Rosconi 57 FermaVir 57 Mipomersen 57 docetaxel Taxotere ® 57 oral dual endothelin 57 OncoVex 57 Aphthasol R 57 ENRICH trial 57 CONBRIZA 57 anticancer compound 57 mtm laboratories 57 Lantibio 57 Steven B. Ratoff 57 JOULFERON 57 IMPACT IMmunotherapy 57 Cytolin 57 HCV protease inhibitor 57 Nautilus Biotech 57 ORTHOCON 57 BioSTAR R 57 Vernalis plc 57 docetaxel Taxotere R 57 oral antiviral 57 Vitaxin 57 Fodosine 57 Somatuline Depot 57 Valera Pharmaceuticals 57 ThromboGenics NV 57 huC# DM4 57 Pivotal Phase II 57 Pervasis 57 Pre IND 57 volociximab 57 Phase lll 57 MediGene 57 MORAb 57 Esmya 57 Febuxostat 57 MyVax ® 57 ViaCyte 57 NYSE Amex PTN 57 nalbuphine ER 57 GammaCan 57 Files IND 57 Exherin 57 ularitide 57 celgosivir 57 Dr. Pingpank 57 SinuNase TM 57 Ascend Therapeutics 57 ixabepilone 57 Diamyd ® 57 Barry D. Quart 57 Rapinyl 57 pain palliation 57 vascular disrupting agents 57 Kosan dependence 57 DAIICHI SANKYO 57 Tesmilifene 57 Ipsen Euronext FR# 57 Aplidin 57 MolMed 57 Azedra TM 57 Tracleer r 57 PSMA ADC 57 PhosLo 57 KRN# 57 CCX# B 57 PXD# 57 t2cure GmbH 57 Combidex 57 ARIKACE ™ 57 BUPHENYL R 57 Announcement acc 57 Xanafide 57 Increlex R 57 CEQ# 57 ridaforolimus 57 SNT MC# 57 Angiocept 57 JAK inhibitor 57 Triapine R 57 Trophos 57 Voraxaze ™ 57 OGeS 57 Symadex 57 PLK1 SNALP 57 Presents Preclinical Data 57 Vion Pharmaceuticals 57 Daclizumab 57 ProtAffin 57 Photocure 57 Biologic License Application BLA 57 Pirfenidone 57 PRT# 57 Georges Gemayel 57 tanespimycin 57 HELSINN 57 ATL# [002] 57 Ridaforolimus 57 E Ointment 57 Therinject 57 Ore Pharmaceuticals 57 Veridex LLC 57 TLK# 57 HaptoGuard 57 IMC #B 57 EXPAREL ™ 57 preclinically 57 ThermoDox R 57 Eligard ® 57 Vegenics 57 GSK '# 57 Zingo TM 57 aurora kinase 57 Swedish Orphan Biovitrum 57 Annamycin 57 Ampio 57 SuperAntibody 57 Theramex 57 Japanese Encephalitis vaccine 57 Sanochemia 57 TYZEKA 57 BioInvent 57 Cethrin 57 pharmacokinetic PK study 57 vinca alkaloid 57 Expression Genetics 57 Zemiva TM 57 Onconase 57 Molecular Insight 57 Phase IIB 57 Triapine 57 orphan medicinal product 57 RECOTHROM R 57 Raptiva R 57 Campath ® 57 PHX# 57 Trobalt 57 Lung Rx 57 Celution TM System 57 EndoTAG TM 57 talactoferrin 57 EGS# 57 INTEGRILIN R eptifibatide Injection 57 Genitope Corporation 57 intravesical infusion therapy 57 Specifid 57 oncolytic vaccine 57 Sanochemia Pharmazeutika AG 57 incyclinide 57 Pieris AG 57 www.cellgenesys.com 57 Microwave Ablation System 57 IMMCO 57 BEMA TM Fentanyl 57 Scil Proteins 57 Rotarix R 57 pivotal bioequivalence 57 OPAXIO 57 SMT C# 57 IND submission 57 personalized immunotherapy 57 pertuzumab 57 Medidur FA 57 IV Busulfex 57 WILEX AG 57 Emisphere Technologies 57 Increlex TM 57 ViRexx 57 Phase III confirmatory 57 methylnaltrexone 57 CHMP recommendation 57 ATPace 57 BCIRG 57 Stanate R 57 Neogenix 57 Flutiform TM 57 Staphylococcus aureus Polysaccharide Conjugate 57 SWX SPPN 56 CancerVax Corporation 56 FOLOTYN ® 56 personalized dendritic 56 Bortezomib 56 PGL# 56 Thiovir 56 Harbor BioSciences 56 Eligard R 56 Aurora kinase inhibitor 56 Onalta 56 Loramyc TM 56 Phase #/#a trial 56 kidney urologic 56 Viventia Biotech 56 Janssen Pharmaceutica NV 56 alemtuzumab Campath 56 defensin mimetic antibiotic 56 Abstral ® 56 Santhera 56 Igeneon 56 Prostate AdenoCarcinoma Treatment 56 oral proteasome inhibitor 56 BioGlue ® 56 2 inhibitor CYT# 56 lintuzumab 56 IV APAP 56 treat chronic sinusitis 56 ORE# 56 oral methylnaltrexone 56 valopicitabine NM# 56 Apricus Bio 56 reslizumab 56 hyaluronidase enzyme 56 THR beta agonist 56 DepoDur 56 Juvaris BioTherapeutics 56 CMV vaccine 56 LibiGel NDA 56 tumor vascular disrupting 56 MyVax R 56 Bellicum 56 Initiate Clinical Trial 56 HepeX B 56 HGS# 56 Aviptadil 56 ACCLAIM II 56 Clinical Trial Results 56 rALLy trial 56 IIa clinical 56 Pharmexa 56 Receives CE Marking 56 Daniel Junius 56 Voraxaze 56 Cethrin R 56 Apthera 56 Oncoscience AG 56 Epratuzumab 56 PSN# [002] 56 Albugon 56 EVIZON TM 56 Etubics 56 Alocrest 56 Eurand 56 Loramyc ® 56 AVAX Technologies 56 molecular chaperone regulation 56 Loramyc ™ 56 CBLC# 56 Squalamine 56 ChemoCentryx 56 Ortec 56 Aquinox 56 Phase III psoriasis 56 Ceplene ® histamine dihydrochloride 56 AviaraDx 56 Pepscan 56 MERLIN TIMI 56 Myrexis 56 AFFiRiS 56 Acologix 56 XTENT 56 Recombinant Human 56 oxymorphone ER 56 Eximias Pharmaceutical Corporation 56 ViiV Healthcare 56 Noscira 56 Liprotamase 56 Reverset 56 DAVANAT 56 OMNARIS HFA 56 diagnostic radiopharmaceutical 56 elacytarabine 56 Nexavar sorafenib 56 HuLuc# 56 miconazole MBT 56 adenoviral vectors 56 RPL# 56 Mr. Kriegsman 56 Welichem 56 NO# [002] 56 AIM SLN Silence 56 Carfilzomib 56 Legacy Biotechnologies 56 Agenus 56 TACI Ig 56 granted Ortec 56 Nasdaq ENZN 56 Numoda 56 Lixivaptan 56 TiGenix 56 Hexvix ® 56 Intravenous Human 56 Nanobody R 56 Dr. Fahar Merchant 56 Scivanta 56 ThromboGenics commenting 56 Corixa Corporation 56 novel synthetic peptide 56 huN# DM1 56 Current Controlled Trials 56 tramiprosate ALZHEMED TM 56 Nanobiotix 56 Alvine Pharmaceuticals 56 Sigma Tau Pharmaceuticals 56 IMiDs R 56 GeneMax 56 brivaracetam 56 Levoleucovorin 56 bioFILM PA TM 56 ponatinib 56 EVICEL 56 Zenpep 56 BiTE R 56 CURE AF 56 fipamezole 56 fostamatinib 56 AMEX RGN 56 BENLYSTA ® 56 Sirion Therapeutics 56 Arcion 56 rhMBL 56 assessing T DM1 56 telaprevir VX 56 Stressgen 56 Janssen Alzheimer Immunotherapy 56 PSN# [001] 56 Bayer HealthCare Onyx Pharmaceuticals 56 Restanza 56 ASH Annual Meeting 56 NSABP 56 R#/MEM # 56 candidate epratuzumab 56 DermaVir Patch 56 vascular disrupting agent 56 Tectin TM 56 Extina 56 Anavex #-# 56 Rhein Biotech 56 CCR5 mAb 56 SILENOR 56 TOPIGEN 56 Innate Pharma 56 thalidomide Thalomid 56 Intendis 56 GRN# 56 Dexo 56 CureVac 56 Myrexis Inc. 56 Orazol 56 initiate Phase IIb 56 Anticancer Drug 56 Pierre Fabre Medicament 56 Hyphanox 56 LymphoStat B TM 56 HspE7 56 HSP# inhibitor 56 RH1 56 p# inhibitor 56 ATryn ® 56 SCHWARZ PHARMA 56 Syndax 56 AMPK activators 56 AcryMed Incorporated 56 Diasome 56 PRAECIS PHARMACEUTICALS INCORPORATED 56 Alnylam #x# 56 Zebinix R 56 antiviral therapeutics 56 DMAG 56 liposomal formulation 56 Auxilium Pharma 56 Orexo 56 APEX PD 56 Nitec Pharma 56 Inc. OTCBB SPRX 56 velafermin 56 GRAVITAS trial 56 novel immunotherapeutic 56 ofatumumab HuMax CD# 56 SpePharm 56 Reports Preclinical Data 56 sumatriptan DosePro 56 Dr. Aiping Young 56 Aloxi R 56 OvaRex 56 Removab 56 non nucleoside HCV 56 Solasia 56 Multimeric 56 Submits NDA 56 OncoGel 56 Kiadis 56 JenaValve 56 Cortria 56 humanised monoclonal antibody 56 Mr. Yves Rosconi 56 OMAPRO 56 BEMA Fentanyl 56 indibulin 56 Muraglitazar 56 eTag assays 56 lorcaserin Phase 56 Cytta Corp. 56 CyDex Pharmaceuticals 56 SinuNase 56 Nasdaq CYCC Nasdaq CYCCP 56 Ambrisentan 56 Aerie Pharmaceuticals 56 Antibody Therapeutics 56 CDP# 56 HCl Tablets 56 Joanna Horobin MD 56 Nasdaq ALXN 56 renin inhibitor 56 KIACTA ™ 56 multicenter Phase II 56 Tobira Therapeutics 56 AMEX ONI 56 Ixempra 56 Phase 1b clinical trials 56 proteasome inhibitor 56 Inflazyme 56 Ceragenin ™ 56 Safinamide 56 Maribavir 56 Endotis 56 pafuramidine 56 Tyzeka Sebivo 56 Anaphore 56 PEG SN# 56 Hexvix 56 balsalazide tablet 56 ThyroTest R 56 Conatus Pharmaceuticals 56 ProMune 55 Sidec 55 refractory chronic lymphocytic 55 Tarceva TM 55 Luteinizing Hormone Releasing Hormone 55 topically applied SEPA 55 Debiopharm SA 55 BioAlliance Pharma 55 Urodynamix 55 Robert L. Bratzler 55 Portola Pharmaceuticals 55 Investigational Oral 55 Allovectin 7 r 55 TRACON Pharmaceuticals 55 Begins Dosing 55 BioXell 55 novel peptides 55 darinaparsin ZIO 55 H3 Pharma 55 SAR# [002] 55 THALOMID 55 Somatuline Autogel 55 Caleco Pharma 55 Tarvacin TM 55 thetreatment 55 CAELYX 55 Dr. McHutchison 55 Synta Announces 55 Firazyr 55 EKR 55 Cytokine PharmaSciences 55 STRIDE PD 55 severe hypercholesterolemia 55 Aloxi ® 55 ESBATech 55 Frova ® 55 Vitalstate 55 ExonHit 55 Nicotine Conjugate Vaccine 55 Vaxfectin R adjuvant 55 Tranzyme Pharma 55 NanoCrystal technology 55 GLP toxicology studies 55 oral treprostinil 55 Adenuric ® 55 acetonide FA 55 Endovascular System 55 Nanobody ® 55 Akorn Strides 55 Orqis Medical 55 Receptos 55 novel anticancer 55 Omthera 55 BioTie 55 OXi# 55 Xcytrin R 55 NOXXON 55 XL# XL# 55 Addex Pharmaceuticals SWISS ADXN 55 REVIVE Diabetes 55 SEBIVO 55 InNexus Biotechnology 55 Phase Ib 55 CIP TRAMADOL ER 55 Envirokare Tech Inc. 55 Ophthotech 55 Diatos